Freed vs Revvity
Side-by-side comparison of AI visibility scores, market position, and capabilities
AI medical scribe used by 20,000+ clinicians at $99/mo. $20M+ ARR. 32M+ patient visits transcribed. $30M Series A led by Sequoia Capital. Founded 2022, SF. Private.
About
Freed is an AI medical scribe founded in 2022 by CEO Erez Druk, headquartered in San Francisco. The platform listens to patient-clinician encounters and automatically generates structured clinical notes including SOAP notes, referral letters, patient instructions, and ICD-10/CPT billing codes. Priced at $99/month per clinician vs $25-50/hour for human scribes.
Revvity (RVTY) reported ~$2.9B revenue in FY2024. Life science tools and diagnostics company providing instruments, reagents, and software for genomics, newborn screening, and drug discovery. HQ: Waltham, MA.
About
Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provider of solutions for reproductive health, genomics, and applied markets. The company operates in two segments: Life Sciences (analytical instruments, reagents, software for pharmaceutical and academic research) and Diagnostics (immunoassay and molecular diagnostic systems for clinical and screening applications). Revvity is the global leader in newborn screening, processing the tests that check newborns for metabolic and genetic disorders shortly after birth.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.